Sumit Kar

1.1k total citations
18 papers, 601 citations indexed

About

Sumit Kar is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Sumit Kar has authored 18 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Sumit Kar's work include Cardiovascular Function and Risk Factors (3 papers), Sulfur Compounds in Biology (3 papers) and Renin-Angiotensin System Studies (3 papers). Sumit Kar is often cited by papers focused on Cardiovascular Function and Risk Factors (3 papers), Sulfur Compounds in Biology (3 papers) and Renin-Angiotensin System Studies (3 papers). Sumit Kar collaborates with scholars based in United States, Switzerland and Slovakia. Sumit Kar's co-authors include Paras K. Mishra, Irving H. Zucker, Santosh K. Yadav, Lie Gao, Sabina Paglialunga, M. Rafiqul Islam, David J. Lefer, James M. Downey, Jason K. Higa and Nicholas K. Kawasaki and has published in prestigious journals such as PLoS ONE, Circulation Research and Clinical Cancer Research.

In The Last Decade

Sumit Kar

17 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumit Kar United States 10 261 241 80 77 70 18 601
Sohel Zaedi Japan 17 183 0.7× 184 0.8× 70 0.9× 134 1.7× 61 0.9× 41 680
Hiroaki Sunaga Japan 17 321 1.2× 210 0.9× 94 1.2× 101 1.3× 45 0.6× 33 799
Elaine Hillas United States 13 286 1.1× 542 2.2× 116 1.4× 100 1.3× 76 1.1× 21 961
Fei Fang Canada 11 240 0.9× 171 0.7× 67 0.8× 101 1.3× 18 0.3× 16 649
Yun Ti China 14 202 0.8× 199 0.8× 115 1.4× 92 1.2× 17 0.2× 45 564
Margareta Scharin Täng Sweden 15 220 0.8× 406 1.7× 91 1.1× 54 0.7× 50 0.7× 27 696
Bryan T. Hackfort United States 11 245 0.9× 137 0.6× 50 0.6× 34 0.4× 61 0.9× 19 490
Jana Grune Germany 16 252 1.0× 341 1.4× 174 2.2× 64 0.8× 39 0.6× 45 904
Xiangquan Kong China 15 179 0.7× 119 0.5× 114 1.4× 56 0.7× 30 0.4× 36 546
Marte Bliksøen Norway 9 525 2.0× 239 1.0× 167 2.1× 77 1.0× 78 1.1× 12 821

Countries citing papers authored by Sumit Kar

Since Specialization
Citations

This map shows the geographic impact of Sumit Kar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumit Kar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumit Kar more than expected).

Fields of papers citing papers by Sumit Kar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumit Kar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumit Kar. The network helps show where Sumit Kar may publish in the future.

Co-authorship network of co-authors of Sumit Kar

This figure shows the co-authorship network connecting the top 25 collaborators of Sumit Kar. A scholar is included among the top collaborators of Sumit Kar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumit Kar. Sumit Kar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schram, Alison M., Abdul Rafeh Naqash, Eric B. Haura, et al.. (2025). The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial. Clinical Cancer Research. 31(23). 4933–4943.
2.
Kar, Sumit, et al.. (2021). Generating Ins2+/−/miR-133aTg Mice to Model miRNA-Driven Cardioprotection of Human Diabetic Heart. Methods in molecular biology. 2224. 113–121. 5 indexed citations
3.
Yadav, Santosh K., et al.. (2020). MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro. Cell Death and Disease. 11(3). 186–186. 51 indexed citations
4.
Kar, Sumit, et al.. (2020). Abstract 501: Hydrogen Sulfide Protects the Heart Against Ferroptotic Cell Death in Diabetic Cardiomyopathy. Circulation Research. 127(Suppl_1). 2 indexed citations
5.
Kar, Sumit & M. Rafiqul Islam. (2020). Rapid and Robust Bioanalytical Assays are Critical for SARS-CoV-2 Therapeutic and Vaccine Development and Beyond. Bioanalysis. 12(17). 1199–1203. 1 indexed citations
6.
Kar, Sumit, et al.. (2019). Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. PLoS ONE. 14(7). e0217263–e0217263. 20 indexed citations
7.
Kar, Sumit, et al.. (2019). Transgenic Expression of miR-133a in the Diabetic Akita Heart Prevents Cardiac Remodeling and Cardiomyopathy. Frontiers in Cardiovascular Medicine. 6. 45–45. 31 indexed citations
8.
Kar, Sumit, et al.. (2019). Hydrogen Sulfide Ameliorates Homocysteine-Induced Cardiac Remodeling and Dysfunction. Frontiers in Physiology. 10. 598–598. 38 indexed citations
9.
Mishra, Paras K., Adriana Adameová, Joseph A. Hill, et al.. (2019). Guidelines for evaluating myocardial cell death. American Journal of Physiology-Heart and Circulatory Physiology. 317(5). H891–H922. 178 indexed citations
10.
Kar, Sumit, et al.. (2019). New Approaches for Biomarker Stability Determination in Regulated Bioanalysis: Trending, Bridging and Incurred Samples. Bioanalysis. 11(20). 1837–1844. 2 indexed citations
11.
Kar, Sumit, et al.. (2019). Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 316(6). H1237–H1252. 41 indexed citations
12.
Kar, Sumit, Bryan T. Hackfort, Santosh K. Yadav, et al.. (2019). Exercise Training Promotes Cardiac Hydrogen Sulfide Biosynthesis and Mitigates Pyroptosis to Prevent High-Fat Diet-Induced Diabetic Cardiomyopathy. Antioxidants. 8(12). 638–638. 70 indexed citations
13.
Islam, M. Rafiqul, et al.. (2018). Adaptation of Commercial Biomarker Kits and Proposal for ‘Drug Development Kits’ to Support Bioanalysis: Call for Action. Bioanalysis. 10(12). 945–955. 1 indexed citations
14.
Kar, Sumit, Sabina Paglialunga, & M. Rafiqul Islam. (2018). Cystatin C Is a More Reliable Biomarker for Determining eGFR to Support Drug Development Studies. The Journal of Clinical Pharmacology. 58(10). 1239–1247. 50 indexed citations
15.
Kar, Sumit, et al.. (2011). Central Angiotensin (1-7) Enhances Baroreflex Gain in Conscious Rabbits With Heart Failure. Hypertension. 58(4). 627–634. 36 indexed citations
16.
Kar, Sumit, Lie Gao, & Irving H. Zucker. (2010). Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure. Journal of Applied Physiology. 108(4). 923–932. 73 indexed citations
17.
Kar, Sumit, Lie Gao, & Irving H. Zucker. (2009). Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing induced chronic heart failure. The FASEB Journal. 23(S1). 1 indexed citations
18.
Kar, Sumit, Lie Gao, & Irving H. Zucker. (2008). Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing induced chronic heart failure. The FASEB Journal. 22(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026